The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma

Simple Summary Recently, there has been increased recognition of an association between the bacterial microbiome and cancer. In this study, we characterized the non-HPV head and neck squamous cell carcinoma (HNSCC) microbiome. We found a significant enrichment of Fusobacterium, depletion of Streptococcus, and the microbial signatures of twelve bacterial genera distinguishing HNSCC. With increased Fusobacterium—in particular, F. nucleatum—in our HNSCC cohort and its known association with prognosis in colorectal cancers (CRC), we sought to further characterize the association between clinical outcomes and F. nucleatum, and the host interaction with F. nucleatum. We identified a higher abundance of F. nucleatum in non-smokers and an improved survival, in contrast to CRC. An integrative analysis also identified that the enrichment of F. nucleatum was associated with host gene promoter methylation, suggesting that the bacterial mircobiome status may have a potential role as a prognostic biomarker and be involved in the pathogenesis of HNSCC. Abstract The role of oral microbiota in head and neck squamous cell carcinoma (HNSCC) is poorly understood. Here we sought to evaluate the association of the bacterial microbiome with host gene methylation and patient outcomes, and to explore its potential as a biomarker for early detection or intervention. Here we performed 16S rRNA gene amplicon sequencing in sixty-eight HNSCC patients across both tissue and oral rinse samples to identify oral bacteria with differential abundance between HNSCC and controls. A subset of thirty-one pairs of HNSCC tumor tissues and the adjacent normal tissues were characterized for host gene methylation profile using bisulfite capture sequencing. We observed significant enrichments of Fusobacterium and Peptostreptococcus in HNSCC tumor tissues when compared to the adjacent normal tissues, and in HNSCC oral rinses when compared to healthy subjects, while ten other bacterial genera were largely depleted. These HNSCC-related bacteria were discriminative for HNSCC and controls with area under the receiver operating curves (AUCs) of 0.84 and 0.86 in tissue and oral rinse samples, respectively. Moreover, Fusobacterium nucleatum abundance in HNSCC cases was strongly associated with non-smokers, lower tumor stage, lower rate of recurrence, and improved disease-specific survival. An integrative analysis identified that enrichment of F. nucleatum was associated with host gene promoter methylation, including hypermethylation of tumor suppressor genes LXN and SMARCA2, for which gene expressions were downregulated in the HNSCC cohort from The Cancer Genome Atlas. In conclusion, we identified a taxonomically defined microbial consortium associated with HNSCC that may have clinical potential regarding biomarkers for early detection or intervention. Host–microbe interactions between F. nucleatum enrichment and clinical outcomes or host gene methylation imply a potential role of F. nucleatum as a pro-inflammatory driver in initiating HNSCC without traditional risk factors, which warrants further investigation for the underlying mechanisms.

[1]  E. Giannoulatou,et al.  Multi-omic profiling reveals associations between the gut mucosal microbiome, the metabolome, and host DNA methylation associated gene expression in patients with colorectal cancer , 2020, BMC Microbiology.

[2]  Yuexian Li,et al.  Transcription levels and prognostic significance of the NFI family members in human cancers , 2020, PeerJ.

[3]  Ze Lu,et al.  Fusobacterium nucleatum Caused DNA Damage and Promoted Cell Proliferation by the Ku70/p53 Pathway in Oral Cancer Cells , 2019, DNA and cell biology.

[4]  A. Schlattl,et al.  SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines , 2019, Scientific Reports.

[5]  Stuart M. Brown,et al.  Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus , 2019, International journal of cancer.

[6]  Francesco Asnicar,et al.  Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.

[7]  Junjie Yang,et al.  Compositional and Functional Analysis of the Microbiome in Tissue and Saliva of Oral Squamous Cell Carcinoma , 2019, Front. Microbiol..

[8]  A. Clayton,et al.  The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy , 2019, Scientific Reports.

[9]  Jixiang Wu,et al.  Inactivation of SMARCA2 by promoter hypermethylation drives lung cancer development. , 2019, Gene.

[10]  S. Ng,et al.  Impact of Preservation Method and 16S rRNA Hypervariable Region on Gut Microbiota Profiling , 2019, mSystems.

[11]  A. E. del Río Hernández,et al.  Role of Extracellular Matrix in Development and Cancer Progression , 2018, International journal of molecular sciences.

[12]  C. Yen,et al.  The interplay between oral microbiome, lifestyle factors and genetic polymorphisms in the risk of oral squamous cell carcinoma , 2018, Carcinogenesis.

[13]  C. Liao,et al.  Oral Microbiota Community Dynamics Associated With Oral Squamous Cell Carcinoma Staging , 2018, Front. Microbiol..

[14]  Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancer , 2018, Infectious Agents and Cancer.

[15]  Zigui Chen,et al.  Prevalence and Epidemiologic Profile of Oral Infection with Alpha, Beta, and Gamma Papillomaviruses in an Asian Chinese Population , 2018, The Journal of infectious diseases.

[16]  A. Lin.  Radiation Therapy for Oral Cavity and Oropharyngeal Cancers. , 2018, Dental clinics of North America.

[17]  L. Marchionni,et al.  High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation , 2017, Oncotarget.

[18]  Y. Nakagawa,et al.  Potential link between Fusobacterium enrichment and DNA methylation accumulation in the inflammatory colonic mucosa in ulcerative colitis , 2017, Oncotarget.

[19]  T. Chan,et al.  Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract , 2017, Oncotarget.

[20]  Jinze Liu,et al.  Latexin Inactivation Enhances Survival and Long-Term Engraftment of Hematopoietic Stem Cells and Expands the Entire Hematopoietic System in Mice , 2017, Stem cell reports.

[21]  Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas , 2017, Genome Medicine.

[22]  E. Keller,et al.  Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance , 2017, Molecular Cancer Research.

[23]  Stéphanie Bougeard,et al.  MINT: a multivariate integrative method to identify reproducible molecular signatures across independent experiments and platforms , 2016, BMC Bioinformatics.

[24]  Jun Wang,et al.  Metagenome-wide association studies: fine-mining the microbiome , 2016, Nature Reviews Microbiology.

[25]  D. Sidransky,et al.  16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment , 2016, Oncotarget.

[26]  R. Shaw,et al.  Aetiology and risk factors for head and neck cancer: United Kingdom National Multidisciplinary Guidelines , 2016, The Journal of Laryngology & Otology.

[27]  A. Buhmeida,et al.  High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma. , 2016, Future oncology.

[28]  Lingling Zhou,et al.  Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma , 2015, Oncology reports.

[29]  Mingyang Song,et al.  Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis , 2015, Gut.

[30]  I. Ganly,et al.  The oral microbiome and oral cancer. , 2014, Clinics in laboratory medicine.

[31]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[32]  D. S. St. Clair,et al.  Latexin sensitizes leukemogenic cells to gamma-irradiation-induced cell-cycle arrest and cell death through Rps3 pathway , 2014, Cell Death and Disease.

[33]  Rob Knight,et al.  The Earth Microbiome project: successes and aspirations , 2014, BMC Biology.

[34]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[35]  J. Goedert,et al.  Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.

[36]  Robert C. Edgar,et al.  UPARSE: highly accurate OTU sequences from microbial amplicon reads , 2013, Nature Methods.

[37]  M. R. Rubinstein,et al.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.

[38]  N. Schork,et al.  The Dental Plaque Microbiome in Health and Disease , 2013, PloS one.

[39]  Francine E. Garrett-Bakelman,et al.  methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles , 2012, Genome Biology.

[40]  Jonathan Friedman,et al.  Inferring Correlation Networks from Genomic Survey Data , 2012, PLoS Comput. Biol..

[41]  M. Brandwein-Gensler,et al.  Human Papillomavirus in Non-Oropharyngeal Head and Neck Cancers: A Systematic Literature Review , 2012, Head and Neck Pathology.

[42]  Y. Furukawa,et al.  Latexin regulates the abundance of multiple cellular proteins in hematopoietic stem cells , 2012, Journal of cellular physiology.

[43]  Richard A. Moore,et al.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.

[44]  Felix Krueger,et al.  Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..

[45]  E. Virginia Armbrust,et al.  pplacer: linear time maximum-likelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree , 2010, BMC Bioinformatics.

[46]  J. Wactawski‐Wende,et al.  Chronic Periodontitis and the Incidence of Head and Neck Squamous Cell Carcinoma , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[47]  Steven S. Chang,et al.  Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma , 2008, Clinical Cancer Research.

[48]  D. Reisman,et al.  The reversible epigenetic silencing of BRM: implications for clinical targeted therapy , 2007, Oncogene.

[49]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[50]  J. Jen,et al.  Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. , 2001, Cancer research.

[51]  L. Hansson,et al.  Prevalence of Helicobacter pylori infection in subtypes of gastric cancer , 1995 .

[52]  Alter Mj,et al.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. , 1991, BMJ.